13G Filing: Cormorant Asset Management and Trillium Therapeutics Inc. (TRIL)

Page 10 of 10

Page 10 of 10 – SEC Filing

CUSIP NO.    89620X506
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.
June 5, 2017
CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP
By:  Cormorant Global Healthcare GP, LLC
        its General Partner
By:  /s/ Bihua Chen
Bihua Chen, Managing Member
CORMORANT GLOBAL HEALTHCARE GP, LLC
By:  /s/ Bihua Chen
Bihua Chen, Managing Member
CORMORANT ASSET MANAGEMENT, LLC
By:  /s/ Bihua Chen
Bihua Chen, Managing Member
/s/ Bihua Chen
Bihua Chen

Follow Trillium Therapeutics Inc. (NASDAQ:TRIL)

Page 10 of 10